Page last updated: 2024-11-06

n-epsilon-acetyllysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-epsilon-acetyllysine (ε-N-acetyllysine) is a post-translational modification of lysine residues in proteins. It is formed by the transfer of an acetyl group from acetyl coenzyme A (acetyl-CoA) to the ε-amino group of lysine. This modification is catalyzed by lysine acetyltransferases (KATs), which are a family of enzymes that play important roles in various cellular processes, including gene regulation, DNA repair, and protein stability. Acetylation of lysine residues can alter the structure and function of proteins by affecting their interactions with other molecules, such as DNA, RNA, or other proteins. The study of ε-N-acetyllysine is important because it provides insights into the regulation of various cellular processes and the role of acetylation in health and disease. For instance, ε-N-acetyllysine modifications have been implicated in the development of cancer and neurodegenerative disorders. Research on ε-N-acetyllysine focuses on understanding the mechanisms of its regulation, its role in different cellular pathways, and its potential as a therapeutic target.'

N(6)-acetyl-L-lysine : An N(6)-acyl-L-lysine where the N(6)-acyl group is specified as acetyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92832
CHEMBL ID1230958
CHEBI ID17752
SCHEMBL ID236178
MeSH IDM0067341

Synonyms (63)

Synonym
CHEMBL1230958
n(6)-acetyl-l-lysine
n(zeta)-acetyllysine
n(6)-acetyllysine
n(epsilon)-acetyl-l-lysine
(2s)-6-(acetylamino)-2-aminohexanoic acid
n-epsilon-acetyl-l-lysine ,
CHEBI:17752 ,
n(zeta)-acetyl-l-lysine
n-epsilon-acetyllysine
692-04-6
n6-acetyl-l-lysine
C02727
nepsilon-acetyl-l-lysine
epsilon-n-acetyl-l-lysine
FB4777AC-AEFF-40D6-B766-C84C543F5479
BMSE000353
e-acetyl-l-lysine
n6-acetyllysine
(2s)-6-acetamido-2-aminohexanoic acid
einecs 211-725-9
470ad5vy1x ,
unii-470ad5vy1x
omega-acetyllsine
n(6)-acetyllsine
nsc 102777
h-lys(ac)-oh
n.epsilon.-acetyl-l-lysine
.epsilon.-n-acetyllysine
SCHEMBL236178
(s)-6-acetamido-2-aminohexanoic acid
l-lysine, n6-acetyl-
F0001-3143
n-.epsilon.-acetyl-l-lysine
DTERQYGMUDWYAZ-ZETCQYMHSA-N
l-lysine, n(6)-acetyl-
mfcd00002639
(2s)-2-amino-6-acetamidohexanoic acid
w-n-acetyl-l-lysine
e-n-acetyl-l-lysine
n-e-acetyl-l-lysine
ne-acetyllysine
l-epsilon-n-acetyllysine
l-e-n-acetyllysine
n-e-acetyllysine
omega-n-acetyl-l-lysine
ne-acetyl-l-lysine
e-n-acetyllysine
epsilon-acetyl-l-lysine
epsilon-n-acetyllysine
CS-0059465
HY-113426
n~6~-acetyl-l-lysine
Q4673311
F10994
AS-46943
6-n-acetyl-l-lysine-3,3,4,4,5,5,6,6-d8
A866889
AKOS016844372
S6075
DTXSID90862371
EN300-7365557
h-l-lys(ac)-oh
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
acetyl-L-lysineAn N-acetyl-L-amino acid that is the N-acetyl derivative of L-lysine.
N(6)-acyl-L-lysineAny N-acyl-L-alpha-amino acid that is L-lysine in which the N(6) amino group has been acylated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Lysine degradation ( Lysine degradation )2029
N6-Acetyl-L-lysine + 2-Oxo-glutaric acid = 6-Acetamido-2-oxo-hexanoic acid + L-Glutamic acid ( Lysine degradation )14
Biochemical pathways: part I0466

Bioassays (3)

Assay IDTitleYearJournalArticle
AID513346Inhibition of wild-type Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc assessed as reduction of beta-galactosidase activity at 5 mM after 3 hrs by lacZ reporter gene assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513343Binding affinity to Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc by in-line probing assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513357Antibacterial activity against Bacillus subtilis 168 1A1 after 24 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (25.58)18.7374
1990's13 (30.23)18.2507
2000's13 (30.23)29.6817
2010's6 (13.95)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.59 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]